LFWD Company Profile and Key Details

Lifeward Ltd. (NASDAQ:LFWD) closed at $7.25 USD, losing -$0.15 (-2.03%) from the previous close of $7.40. The stock is currently mid-range between its 52-week high and low $4.14 and $10.56. With a market capitalization of about $11.68 million, Lifeward Ltd. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.40). Key stats such as the average daily volume over the past year has been around 9.74 thousand shares, volume is running light vs its 52-week average. Headquartered in Yokneam Illit, MA, Lifeward Ltd. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO William Mark Grant, the company employs approximately 81 people and listed since September 12, 2014. Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons.

Lifeward Ltd. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$4.89. This means the shares are trading below this model’s fair value.

Lifeward Ltd. has 15.60 million shares outstanding. The public float is 15.42 million shares, elevated short interest at 9.67% of float. This equals 1.48 million shares. The short ratio is 2.19 days. Institutional investors hold 1.5% of the float. Insiders own 47.45%. Lind Global Fund II LP holds 858.00 thousand shares, Jasinski Lawrence J has 98.73 thousand shares and Swinford Michael has 65.04 thousand shares.

Short-term trend indicators are bullishly aligned (SMA20 2.06%, SMA50 -10.42%, SMA200 -25.97%). The stock’s 14-day RSI is 49.39 (neutral), while the ATR of 0.71 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -81.72% below its high and over 56.28% above its low. Average 10-day trading volume of 4.43 thousand shares is below the 3-month average of 9.49 thousand, indicating normal recent market interest.

Lifeward Ltd. generated EPS of -$35.73 over the past year. Five-year average earnings growth is 29.33%. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 2 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $10.00 to $4.50. The high target offers 37.93% upside. The low target suggests -37.93% downside. The mean target is $7.25. This offers 0.0% upside. Lifeward Ltd. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended August 14, 2026, missed forecasts by 5.04%. The prior quarter beat by 165.25%. Over the last six quarters, Apple has recorded several small beats. These include 39.39% in May 15, 2025.

Lifeward Ltd. trades at a P/E ratio of -0.42, slightly below the S&P 500 average, with a price-to-sales ratio of 0.53 and a price-to-book ratio of 1.63 suggesting the stock is closer to book value. The P/FCF stands at -0.67, also above market averages.

Lifeward Ltd. (NASDAQ:LFWD) shares are up 25.06% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Lifeward Ltd. trading at a premium to the broader market with a P/E of -0.42. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $9.00, suggesting 24.14% upside. Our AI forecast model points to short-term weakness (-0.41% over two weeks), a medium-term fall (-45.24% over three months), and a longer-term gain (46.9% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Lifeward Ltd. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -0.41%, with price expected at $7.22 by September 22, 2026, within a range of $7.01 to $7.44 3-Month Outlook: Projected fall of -45.24%, reaching $3.97 by December 07, 2026, with a range of $3.32 to $4.32. 1-Year Outlook: Projected gain of 46.9%, with price at $10.65 by September 08, 2027, within a range of $1.74 to $9.01.